imjudo - tremelimumab injection, solution
(Tremelimumab)Astrazeneca Pharmaceuticals Lp
Increased T Lymphocyte Activation [PE] class drugs
4 results
kymriah
(Tisagenlecleucel)Novartis Pharmaceuticals CorporationUsage: Kymriah is a CD19-directed CAR-T cell therapy for patients up to 25 with refractory or relapsed B-cell precursor ALL; adults with relapsed/refractory large B-cell lymphoma after 2+ prior therapies; and adults with relapsed/refractory follicular lymphoma after 2+ prior therapies (accelerated approval).yervoy - ipilimumab injection
(Ipilimumab)E.R. Squibb & Sons, L.L.C.Usage: Yervoy treats multiple advanced cancers in adults and pediatric patients (12+), including melanoma, renal cell carcinoma, MSI-H colorectal cancer, hepatocellular carcinoma, non-small cell lung cancer, malignant pleural mesothelioma, and esophageal squamous cell carcinoma—primarily in combination with nivolumab.yescarta
(Axicabtagene Ciloleucel)Kite Pharma, Inc.Usage: Yescarta is a CAR-T cell therapy for adults with large B-cell lymphoma refractory to or relapsing after first-line chemoimmunotherapy, or after two or more prior therapies. Also indicated for relapsed or refractory follicular lymphoma after two or more lines of systemic therapy (accelerated approval).